Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Scienture Holdings (SCNX) EBT (2016 - 2025)

Scienture Holdings' EBT history spans 13 years, with the latest figure at -$6.7 million for Q2 2025.

  • On a quarterly basis, EBT fell 313.64% to -$6.7 million in Q2 2025 year-over-year; TTM through Jun 2025 was -$18.0 million, a 35.36% decrease, with the full-year FY2025 number at -$43.5 million, down 131.68% from a year prior.
  • EBT hit -$6.7 million in Q2 2025 for Scienture Holdings, down from -$3.1 million in the prior quarter.
  • Over the last five years, EBT for SCNX hit a ceiling of -$340474.0 in Q3 2022 and a floor of -$6.7 million in Q2 2025.
  • Historically, EBT has averaged -$2.2 million across 5 years, with a median of -$1.2 million in 2021.
  • Biggest five-year swings in EBT: plummeted 1040.63% in 2021 and later skyrocketed 73.84% in 2022.
  • Tracing SCNX's EBT over 5 years: stood at -$784340.0 in 2021, then plummeted by 252.67% to -$2.8 million in 2022, then tumbled by 43.67% to -$4.0 million in 2023, then skyrocketed by 59.12% to -$1.6 million in 2024, then plummeted by 313.64% to -$6.7 million in 2025.
  • Business Quant data shows EBT for SCNX at -$6.7 million in Q2 2025, -$3.1 million in Q1 2025, and -$1.6 million in Q2 2024.